Cohen Ron
- SEC CIK
- 0001272354
No open-market purchases or sales filed in the past year.
Current role at each company
- ACOR Acorda Therapeutics, Inc.President and CEOas of Apr 4, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Cohen Ron as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 20, 2023 (view filing) | Mar 16-17 | 4 days | Cohen RonPresident and CEO | PPurchase | +20.2K | $0.6248 | +$12.6K | +15.6%149.8K after | 2 lots |
| Mar 21, 2022 (view filing) | Mar 17 | 4 days | Cohen RonPresident and CEO | SSale | −2.29K | $1.70 | −$3.89K | −1.7%129.6K after |